GRK5 Deficiency Leads to Selective Basal Forebrain Cholinergic Neuronal Vulnerability

Area of Science:

• Neuroscience
• Neurodegenerative Diseases
• Molecular Biology

Background:

• Selective neurodegeneration in specific neuronal subtypes is key to understanding diseases like Alzheimer's.
• Basal forebrain cholinergic (BFC) neurodegeneration is implicated in Alzheimer's disease (AD) cognitive impairment, but mechanisms are unclear.

Purpose of the Study:

• To create and characterize a novel mouse model that recapitulates selective BFC neuronal loss observed in human AD.
• To investigate the role of G protein-coupled receptor kinase-5 (GRK5) in BFC neuronal vulnerability.

Main Methods:

• Generation of GAP mice by crossing Tg2576 (Swedish mutant human amyloid precursor protein) with GRK5 knockout mice.
• Assessment of BFC neuronal loss in GAP mice at 18 months of age.
• Comparison of neuronal loss in GAP mice with parent strains and wild-type controls.

Main Results:

• GAP mice exhibited significant BFC neuronal loss at 18 months.
• No significant BFC neuronal loss was observed in Tg2576, GRK5 knockout, or wild-type mice.
• GRK5 deficiency is proposed to selectively increase BFC neuron vulnerability to degeneration.

Conclusions:

• The GAP mouse model successfully recapitulates selective BFC neurodegeneration characteristic of human AD.
• GRK5 deficiency is identified as a potential factor contributing to the selective vulnerability of BFC neurons in AD pathogenesis.